Blood test breakthrough could spot severe diverticulitis early
NCT ID NCT07322926
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at 101 patients with acute diverticulitis to see if routine blood tests could tell apart mild and severe cases. Researchers compared lab results like white blood cell count and C-reactive protein between the two groups. The goal was to find simple markers that help doctors decide who needs more aggressive treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this research could help doctors quickly identify which diverticulitis patients need more urgent care using routine blood tests.
- What could go wrong
- This is a small, retrospective study that only looks back at past data. The results need to be confirmed in larger, more diverse groups before they can be used in practice.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIVERTICULITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Haydarpasa Numune Research and Training Hospital
Istanbul, 34668, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Heartbeat clues may spot hidden surgical dangers
- Could skipping bowel prep before colon surgery be just as safe?
- Mediterranean diet may ward off painful gut Flare-Ups
- Bridge device for stoma: does it help or hinder?
- New blood test could spot hidden belly infections faster
- Poop pills may tame painful gut Flare-Ups